
Flot.bio x Philip Hemme· Folge 46
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46
Montag, 17. November 2025 · 54 min
Kapitelklicken springt direkt hin
Shownotes
When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge froze Euronext for 45 minutes.
Philip meets Abivax CEO Marc de Garidel in Vienna, Austria, to go behind the scenes of a remarkable biotech turnaround.
Marc discusses the processes involved in executing the phase 3 trial that beat even Abivax’s own phase 2 data. He also talks about France’s biotech ecosystem and the importance of having the right team.
⭐️ ABOUT THE SPEAKER
Marc de Garidel joined Abivax as CEO in 2023. Prior to this, he led two biotech companies through billion-dollar exits (CinCor Pharma and Corvidia Therapeutics). He also served as CEO of Ipsen from 2010 to 2016, and has worked at the likes of Amgen and Eli Lilly.
🔗 LINKS MENTIONED
• Abivax’s website - abivax.com
• Phase 3 results - ir.abivax.com/news-releases/news-release-detai…
• $747.5 million public offering - ir.abivax.com/news-releases/news-release-detai…
• Marc de Garidel, Abivax | How to make two Billion-dollar exits (“smoothly”) | E09 - flot.bio/episode/marc-de-garidel-abivax-exit
• Chris Martin, Verona Pharma 🇬🇧 | Ohtuvayre, COPD, Execution | E34 - flot.bio/episode/chris-martin-verona-pharma-copd
• Christophe Bourdon, LEO Pharma 🇩🇰 | Biopharma Turnaround | E31
• flot.bio/episode/christophe-bourdon-leo-pharma…
• Nanobiotix episode - youtube.com/watch?v=3Krhyy6a-nw&pp=0gcJCQM… (youtube.com/watch?v=3Krhyy6a-nw&pp=0gcJCQM…)
• Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43 - flot.bio/episode/fabrice-chouraqui-pharming-tr…
📜 TRANSCRIPT
Read the full transcript here: flot.bio/episode/marc-de-garidel-abivax-ulcera…
📖 SHORT BLOGS BASED ON THIS EPISODE:
• Abivax's Record NASDAQ Stock Surge After Phase 3 Data: flot.bio/abivax-biotech-stock-phase-3
💸 DONATE
We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: paypal.me/PhilipHemme
⭐️ SPONSORSHIP
Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!
🫶 FOLLOW US
• Newsletter: eepurl.com/h_fnmH
• LinkedIn: linkedin.com/company/flot-bio
• X (Twitter): x.com/FlotBio
🙏 LIKE/FOLLOW/REVIEW
Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.
🎙️ (x.com/FlotBio) ABOUT FLOT.BIO
Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.
⏰ TIMESTAMPS
• : Abivax’s crazy Ph3 data and stock price jump
• : Surging investor demand on NASDAQ and Euronext
• : Future directions
• : Executing a Phase 3 home run
• : Marc de Garidel's leadership style
• : Abivax: origins
• : France's billion-dollar biotechs
• : Quick-fire questions